Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1992 Jun;118(6):441–446. doi: 10.1007/BF01629427

Time-related interference of misoprostol with experimental gastric cancer formation induced byN-methyi-N′-nitro-N-nitrosoguanidine in the rat

N Basso 1,✉, A Materia 1, G Silecchia 1, E Spaziani 1, L Scucchi 2, D Di Stefano 2, P Mingazzini 2, C Favalli 3, E Garaci 3
PMCID: PMC12201576  PMID: 1618891

Abstract

The purpose of this study was to investigate the effect of long-term misoprostol administration, at non-antisecretory doses, onN-methyl-N′-nitro-N-nitrosoguanidine(MNNG)-induced gastric carcinogenesis. The incidence of gastric carcinomas and precancerous lesions was evaluated in 50 male 250-g Sprague-Dawley rats after 52 weeks of continuous oral administration of MNNG (120 mg/l;n=20), MNNG plus misoprostol (2 mg kg−1 day−1;n=20) or tap water (n=10) (experiment 1), and in 30 rats treated with MNNG for 30 weeks followed by tap water (n=15) or by misoprostol (n=15) for 22 weeks; a third group (n=10) received tap water only for 52 weeks (experiment 2). After sacrifice, gastric mucosal lesions were macroscopically evaluated and their histology obtained. MNNG consumption was comparable in all groups (6.5±1.1 mg rat−1 day−1). Misoprostol consumption was 180±0.25 mg kg−1 day−1 rat−1. In experiment 1 the incidence of gastric carcinomas was 60% in the MNNG group and 25% in the group treated with MNNG plus misoprostol (P<0.05). Cytotoxic and hyperplastic gastric mucosal lesions were also significantly reduced by misoprostol. In experiment 2 the incidence of carcinomas was 31% and 38.6% respectively. Misoprostol significantly decreased the incidence of gastric cancer formation when given from the beginning of the experiment. By contrast, when administered after 30 weeks of MNNG treatment it did not interfere with experimental gastric cancer formation. Exogenous prostaglandins are able to prevent the early MNNG-induced gastric mucosal lesions, thus interfering with gastric carcinogenesis.

Key words: Nitroso compounds, Gastric carcinogenesis, Misoprostol

Abbreviation

MNNG

N-methyl-N′-nitro-N-nitrosoguanidine

Footnotes

This work is part of the Panisperna Project on Cancer and was supported by grants from the Ministry of Public Education and the National Research Council

References

  1. Cheli R, Sano L, Giancamerla G, Cangiani G (1973) A clinical and statistical follow-up study of atrophic gastritis. Am J Dig Dis 18:1061–1066 [DOI] [PubMed] [Google Scholar]
  2. Dajani EZ, Driskill DR, Bianchi RG, Collins PW, Pappo R (1976) Sc-29333, a potent inhibitor of canine gastric secretion. Am J Dig Dis 21:1049–1057 [DOI] [PubMed] [Google Scholar]
  3. Fich A, Arber N, Sestrieri M, Zajicek G, Rachmilewitz D (1976) Effect of misoprostol and cimetidine on gastric and duodenal mucosa. Gastroenterology 70:59–65 [DOI] [PubMed] [Google Scholar]
  4. Jacobson ED, Chaudhury TK, Thompson WJ (1976) Mechanism of gastric mucosal cytoprotection by prostaglandins. Gastroenterology 70:A897 [Google Scholar]
  5. Kauffman GC, Grossman MI (1978) Prostaglandin and cimetidine inhibit the formation of antral ulcers produced by salycilates. Gastroenterology 75:1099–1103 [PubMed] [Google Scholar]
  6. Kekki M, Viliako K (1981) Dynamic behaviour of gastritis in various populations and subpopulations. Ann Clin Res 13:119–123 [PubMed] [Google Scholar]
  7. Kerss S, Allen A, Garner A (1982) A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding prostaglandinN-acetylcysteine and other agents. Clin Sci 63:187–195 [DOI] [PubMed] [Google Scholar]
  8. Kunze E, Schauer A, Eder M, Seefiedt L (1979) Early sequential lesions during development of experimental gastric cancer with special reference to dysplasias. J Cancer Res Clin Oncol 95:247–264 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lehnert T, Deschner EE, Kasmali RA, De Cosse JJ (1990) Effect of flurbiprofen and 16,16-dimethyl prostaglandin E2 on gastrointestinal tumorigenesis induced byN-methyl-N-nitro-N-nitrosoguanidine in rats glandular epithelium of stomach and duodenum. Cancer Res 50:381–384 [PubMed] [Google Scholar]
  10. Materia A, Silecchia G, Spaziani E, Scucchi L, Mingazzini P, Favalli C, Garaci E, Basso N (1989) Role of prostaglandins in the early phases of experimental gastric carcinogenesis in the rat. J Cancer Res Clin Oncol 115:253–258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mirvish SS (1983) The ethiology of gastric cancer: intragastric nitrosamides formation and other theories. JNCI 71:631–647 [PubMed] [Google Scholar]
  12. Reed PI (1986) The role of nitrosamines in cancer formation. Bibl Nutr Dieta 30:130–138 [DOI] [PubMed] [Google Scholar]
  13. Robert A (1976) Antisecretory, antiulcers, cytoprotective and diarrheogenic properties of prostaglandins. Adv Thromboxane Prostaglandin Res 2:507–520 [PubMed] [Google Scholar]
  14. Robert A (1979) Cytoprotection by prostaglandin. Gastroenterology 77:761–767 [PubMed] [Google Scholar]
  15. Robert A Nexamis JE, Lancaster C (1979) Cytoprotection by prostagandins in rats: prevention of gastric necrosis produced by alcohol, HCL, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 77:433–443 [PubMed] [Google Scholar]
  16. Robert A, Bottcher W, Galonska S, Kauffman G (1984) Lack of correlation between mucus gel thickness and gastric cytoprotection in rats. Gastroenterology 86:670–674 [PubMed] [Google Scholar]
  17. Rugge M, Baffa R, Farinati F, Di Mario F, Guido M, Valente F, Ninfo V (1991) Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study. Ital J Gastroenterol 23:70–73 [PubMed] [Google Scholar]
  18. Saito T, Inokuchi K, Takayama S, Sugimura T (1970) Sequential morphological changes inN-methyl-N-nitro-N-nitrosoguanidine in the glandular stomach of rats. JNCI 44:769–783 [PubMed] [Google Scholar]
  19. Silecchia G, Materia A, Spaziani E, Mariani P, Scucchi L, Micheli C, Mingazzini P, Mauro F, Favalli C, Basso N (1990) Sequential evaluation of gastric intraluminal prostaglandin E2 release, acid secretion and DNA-flow cytometry inN-methyl-N-nitro-N-nitrosoguanidine gastric carcinogenesis in the rat. Cancer Lett 49:73–80 [DOI] [PubMed] [Google Scholar]
  20. Siurala M, Varis K, Wiljasalo M (1986) Atrophic gastritis: a ten to fifteen years follow-up. Scand J Gastroenterol 1:40–48 [DOI] [PubMed] [Google Scholar]
  21. Sugimura T, Fujimura S (1967) Tumor production in glandular stomach of rat byN-methyl-N-nitro-N-nitrosoguanidine. Nature 216:943–944 [DOI] [PubMed] [Google Scholar]
  22. Sugimura T, Kawachi T (1973) Experimental stomach cancer. Methods Cancer Res 7:245–308 [Google Scholar]
  23. Sugimura T, Kawachi T (1978) Experimental stomach carcinogenesis. In: Lipkin M, Good RA (eds) Gastrointestinal tract cancer. Plenum, New York, pp 327–341 [Google Scholar]
  24. Sugimura T, Fujimura S, Baba T (1970) Tumor production in the glandular stomach and alimentary tract of the rat byN-methyl-N-nitro-N-nitrosoguanidine. Cancer Res 30:455–465 [PubMed] [Google Scholar]
  25. Walker JR, Strickland RG, Ungar B, McKay R (1972) Simple atrophic gastritis and gastric carcinoma. Gut 12:906–913 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES